Avid Bioservices Inc (CDMO)

[stoneroad]

Wook, come the fall PPHM will be making 2017 revenue projections for Avid - likely $50-60 million. No reason with those type of revenue and growth numbers that Avid by itself should not command a MC of at least 4-5x revenue. That alone gets PPHM above $1 per share. IMO Avid has largely been ignored from a valuation perspective. Getting to the size where that can't persist. Not to mention the added credibility brought by the hire PR'd yesterday.

On top of the above (and more importantly), given MSK, NCCN and AZN collaborations, I'm fairly certain that by this fall everyone is going to have a real good idea as to whether Bavi works or not. I'm betting it does!